T1	Outcomes 879 1002	values for plasma amprenavir (APV) area under the concentration-time profile over the dosing interval (tau) at steady state
T2	Outcomes 1017 1134	maximum concentration of drug in plasma (C(max)), and plasma concentration at the end of tau at steady state (C(tau))
T3	Outcomes 1208 1238	AUC(0-tau), C(max), and C(tau)
T4	Outcomes 1405 1446	plasma APV AUC(0-tau), C(max), and C(tau)
T5	Outcomes 1509 1550	plasma RTV AUC(0-tau), C(max), and C(tau)
T6	Outcomes 1746 1792	rate of marked hepatic transaminase elevations
T7	Outcomes 1797 1831	lack of pharmacokinetic advantage.